Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the cardiometabolic diseases market grown in recent years?

In recent times, the market size for cardiometabolic diseases has seen consistent expansion. The market value is anticipated to balloon from $111.64 billion in 2024 to $115.7 billion in 2025, with a compound annual growth rate (CAGR) of 3.6%. The growth during the historic period is linked to factors such as sedentary living, urbanization and changes in lifestyle, industrialization and increased consumption of processed foods, genetic factors, and environmental impacts.

How is the cardiometabolic diseases market size expected to evolve during the forecast period?

The market size for cardiometabolic diseases is projected to progressively expand in the upcoming years, reaching $137.81 billion in 2029 with a compound annual growth rate (CAGR) of 4.5%. The expansion within the projection period can be associated with factors such as the escalating obesity crisis, a perpetually aging population, advancements in healthcare infrastructure, innovations in genomic and precision medicine, as well as chronic stress and mental health issues. Dominant trends within the forecast period encompass health literacy and consciousness, corporate wellness initiatives, community health schemes, prevention-focused healthcare, and holistic care strategies.

Get your cardiometabolic diseases market report here!

https://www.thebusinessresearchcompany.com/report/cardiometabolic-diseases-global-market-report

Which key drivers are propelling the cardiometabolic diseases market’s growth?

The prevalence of cardiometabolic diseases is predicted to rise, driven by the increasing incidence of obesity. This health issue is defined by an excessive accumulation of bodily fat, leading to an elevated body weight. Factors such as dyslipidemia, type 2 diabetes, hypertension, and sleep disturbances significantly related to obesity increase the risk of cardiovascular issues. For example, in March 2022, the Switzerland-based intergovernmental group, the World Health Organization (WHO), reported that obesity affects over 1 billion people worldwide, including 340 million teenagers, 650 million adults, and 39 million children annually. By 2025, the WHO anticipates that being overweight or obese will deteriorate the health of 167 million adults and children. Consequently, the escalating incidence of obesity is fueling the expansion of the cardiometabolic diseases market.

What are the market segments in the cardiometabolic diseases industry?

The cardiometabolic diseases market covered in this report is segmented –

1) By Type: Chronic Or Congestive Heart Failure, Hypertension, Type 2 Diabetes, Obesity

2) By Treatment: ACE inhibitors, Diuretics, Glucophage, Liposuction, Other Treatments

3) By Dosage: Tablet, Injection

4) By Route Of Administration: Oral, Intravenous, Other Routes Of Administration

5) By End-Users: Clinic, Hospital, Other End-Users

Subsegments:

1) By Chronic Or Congestive Heart Failure: Systolic Heart Failure, Diastolic Heart Failure

2) By Hypertension: Primary Hypertension, Secondary Hypertension

3) By Type 2 Diabetes: Insulin Resistance, Impaired Glucose Tolerance

4) By Obesity: Class I Obesity (BMI 30-34.9), Class II Obesity (BMI 35-39.9), Class III Obesity (BMI 40 And above)

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11929&type=smp

Which leading companies are shaping the growth of the cardiometabolic diseases market?

Major companies operating in the cardiometabolic diseases market include Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Kowa Company Ltd., Thermo Fisher Scientific, Abbott Laboratories, Takeda Pharmaceutical Company, Eli Lilly and Company, Novo Nordisk A/S, Siemens Healthineers, Boehringer Ingelheim International GmbH, Becton, Dickinson and Company, Stryker Corporation, AstraZeneca Plc, Viatris Inc., Biocrates Life Sciences AG, Boston Scientific, Astellas Pharma Inc., Terumo Corporation, Agilent Technologies, Edwards Lifesciences, Bruker Corporation, Alnylam Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Cardax Inc.

What key trends are currently impacting the cardiometabolic diseases market’s development?

Embracing cutting-edge technologies is a notable trend rising in prominence in the cardiometabolic diseases market. Firms participating in the cardiometabolic diseases market are focusing on the assimilation of innovative technologies to maintain a competitive edge. For example, in February 2023, Eko Health Inc., an American innovator of heart and lung disease-diagnosing digital health technologies, introduced the Sensora cardiac disease detection platform. This platform employs artificial intelligence (AI) to accurately identify structural murmurs associated with valvular heart disease (VHD) and features a care pathway analytics tool that delivers detailed metrics and insight into the patient’s healthcare trajectory. This digital stethoscope captures and interprets electrical signals and heart rhythms.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11929

Which geographic areas are influencing the growth of the cardiometabolic diseases market?

North America was the largest region in the cardiometabolic diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiometabolic diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/services-global-market-report

Testing, Inspection, And Certification Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/testing-inspection-and-certification-global-market-report

Analytical Standards Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/analytical-standards-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: